Kalaris Therapeutics, Inc. (KLRS) financials
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kalaris Therapeutics, Inc. income statement, balance sheet, and cash flow from the statement cache. Years sit on this URL — not a year mill.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$46.2M | -$65.4M |
| Net Income | -$43.4M | -$58.8M |
| EPS (Diluted) | -$2.85 | -$11.73 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $121.7M | $118.5M |
| Current Assets | $118.8M | $118.5M |
| Cash & Equivalents | $98.1M | $118.3M |
| Total Liabilities | $42.9M | $5.24M |
| Current Liabilities | $9.71M | $5.24M |
| Shareholders' Equity | $78.8M | $113.3M |
| Retained Earnings | -$160.0M | -$715.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$38.4M | -$67.7M |
| CapEx | $200.0K | N/A |
| Investing Cash Flow | -$19.7M | $95.0M |
| Financing Cash Flow | $155.0M | $21.0K |
| Net Change in Cash | $96.9M | $27.3M |
| Free Cash Flow | -$38.6M | N/A |
FAQ
What is KLRS revenue?
KLRS income-statement cache has no revenue figure yet.
Is KLRS profitable?
Kalaris Therapeutics, Inc. last cached net income is -$43.4M (FY2025).
What are KLRS total assets?
Kalaris Therapeutics, Inc. last cached total assets are $121.7M (FY2025).
What is KLRS free cash flow?
Kalaris Therapeutics, Inc. last cached free cash flow is -$38.6M (FY2025).
Not investment advice. Cached statements, not a live tape.